/info/pages/search MenuClose Our Company About Us About Nestlé Health Science Advisory Board Key Investments Values and institutes Nutritional Therapies Newsroom Careers Health Management Aging Dysphagia Healthy aging Malnutrition Brain health Alzheimers Epilepsy Cancer / Oncology Cancer / Oncology My Cancer Nutrition Critical care / Surgery Adult Enteral Nutrition Critical Nutrition Bytes Major surgery Nutrition monitoring in the ICU Target Nutrition App Food Allergy Cow's Milk Protein Allergy Gastro intestinal Constipation Dysphagia Inflammatory bowel disease Irritable bowel syndrome Metabolic diseases Inborn Errors of Metabolism Obesity Obesity Pediatrics Cystic Fibrosis Failure to thrive / Growth delay GI Impairment My child with Cerebral Palsy Neurological disorders Our Brands Althéra • Alfaré • Alfamino BOOST® Compat Diabetisource AC Impact Isosource Meritene Modulen Novasource Nutren Optifast OptiFibre Peptamen Resource Resource ThickenUp SUSTAGEN Vitaflo Newsroom Press releases Events Videos × Results: Nestlé Health Science / Adult Enteral Nutrition / Peptamen Peptamen Intense ADULT ENTERAL NUTRITION MENU ABOUT US BYTES BLOG CASE STUDIES CUSTOMER EXPERIENCE LIBRARY NEWS & EVENTS NUTRIENT SCIENCE PRODUCTS TARGET NUTRITION APP THERAPEUTIC FIELDS Products' Details Target Nutrition App Products PeptamenⓇ Intense Back To Peptamen High protein low carbohydrate enteral formula Optimises delivery of protein and energy in critically ill patients. Peptamen® Intense contains a unique blend of nutrients. Composition of total calories: Metabolic impact clinically demonstrated Shown to facilitate blood glucose management in ICU patients24-25 13% reduction in incidence of hyperglycemia (p = 0.0145) 14% increase in incidence of normoglycemia (p < 0.01) 11% reduction in glycemic excursions (p = 0.01) 11% reduction in the frequency of insulin administration (p = 0.048) Shown to provide better control of postprandial blood glucose when compared to whey/casein formulas Better postprandial blood glucose with Peptamen® Intense: Lower peak blood glucose level Difference in blood glucose level remains significant at 180 min Clinical trends towards lower endogenous insulin production, as measured by serum insulin The use of Peptamen® Intense allowed for increased protein provision without increasing caloric intake in adult critically ill patients receiving propofol. Propofol accounted for apprx 500 kcal/day Protein intake was significantly higher in the Peptamen Intense (VHP EN) group (p=0.044) Daily caloric intake from enteral formula alone was significantly less in the Peptamen® Intense group (p=0.016) Peptamen® Intense allows for provision of nutrients in line with guidelines also in patients receiving substantial non-nutritional calories (e.g. from propofol) References McClave S,et al. ASPEN CNW 2015 (Abstract) Ochoa, et al. JPEN 2017;41(2):289 Ingredients & nutritional tables nestle-monitoring-loaded